You are here

  • Home
  • Archive
  • Volume 9, Issue 3
  • Remission, response, retention and persistence to treatment with disease-modifying agents in patients with rheumatoid arthritis: a study of harmonised Swedish, Danish and Norwegian cohorts

Article info

Article menu

Download PDFPDF

Rheumatoid arthritis
Original research
Remission, response, retention and persistence to treatment with disease-modifying agents in patients with rheumatoid arthritis: a study of harmonised Swedish, Danish and Norwegian cohorts

Authors

  • Helga Westerlind Clinical Epidemiology Division, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden PubMed articlesGoogle scholar articles
  • Bente Glintborg Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, DenmarkDANBIO and Copenhagen Center for Arthritis Research (COPECARE), Centre for Rheumatology and Spine Diseases, Centre of Head and Orthopaedics, Rigshospitalet Glostrup, Glostrup, Denmark PubMed articlesGoogle scholar articles
  • Hilde Berner Hammer Center for treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, NorwayFaculty of Medicine, University of Oslo, Oslo, Norway PubMed articlesGoogle scholar articles
  • Saedis Saevarsdottir Clinical Epidemiology Division, Department of Medicine, Solna, Karolinska Institutet, Stockholm, SwedenFaculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland PubMed articlesGoogle scholar articles
  • Niels Steen Krogh DANBIO and Copenhagen Center for Arthritis Research (COPECARE), Centre for Rheumatology and Spine Diseases, Centre of Head and Orthopaedics, Rigshospitalet Glostrup, Glostrup, Denmark PubMed articlesGoogle scholar articles
  • Merete Lund Hetland Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, DenmarkDANBIO and Copenhagen Center for Arthritis Research (COPECARE), Centre for Rheumatology and Spine Diseases, Centre of Head and Orthopaedics, Rigshospitalet Glostrup, Glostrup, Denmark PubMed articlesGoogle scholar articles
  • Ellen-Margrethe Hauge Department of Rheumatology, Aarhus University Hospital Skejby, Aarhus, DenmarkDepartment of Clinical Medicine, Aarhus University, Aarhus, Denmark PubMed articlesGoogle scholar articles
  • Isabel Martinez Tejada DANBIO and Copenhagen Center for Arthritis Research (COPECARE), Centre for Rheumatology and Spine Diseases, Centre of Head and Orthopaedics, Rigshospitalet Glostrup, Glostrup, Denmark PubMed articlesGoogle scholar articles
  • Joseph Sexton Center for treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway PubMed articlesGoogle scholar articles
  • Johan Askling Clinical Epidemiology Division, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Helga Westerlind; Helga.Westerlind{at}ki.se
View Full Text

Citation

Westerlind H, Glintborg B, Hammer HB, et al
Remission, response, retention and persistence to treatment with disease-modifying agents in patients with rheumatoid arthritis: a study of harmonised Swedish, Danish and Norwegian cohorts
RMD Open 2023;9:e003027. doi: 10.1136/rmdopen-2023-003027

Publication history

  • Received January 24, 2023
  • Accepted July 21, 2023
  • First published September 6, 2023.
Online issue publication 
September 06, 2023

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.